ÂÜÀòÂÒÂ×

David Gelineau, CPA, is an experienced finance professional currently serving as the Controller at Entasis Therapeutics since September 2017. Prior to this role, David held the position of Director of Finance at Enumeral Biomedical Holdings, Inc. from January 2015 to September 2017. Previous experience includes serving as Senior Manager of Finance at Takeda Pharmaceuticals, Accounting Manager at NitroMed, Inc., and Controller at Starbak Communications. David began a career in finance at PwC as an Associate. David holds a Master of Science in Finance and a Bachelor of Science in Accounting, both from Boston College.